Screening for hypoglycemia at the bedside in the neonatal intensive care unit (NICU) with the Abbott PCx glucose meter

被引:30
作者
Balion C. [1 ,2 ]
Grey V. [2 ,3 ]
Ismaila A. [4 ,5 ]
Blatz S. [6 ]
Seidlitz W. [6 ]
机构
[1] Department of Laboratory Medicine, Hamilton Health Sciences, Hamilton, ON
[2] Department of Pathology and Molecular Medicine, McMaster University, Hamilton, ON
[3] Department of Pediatrics, McMaster University, Hamilton, ON
[4] Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON
[5] McMaster University Evidence-based Practice Center (EPC), McMaster University, Hamilton, ON
[6] Department of Pediatrics, Hamilton Health Sciences, Hamilton, ON
关键词
Positive Predictive Value; Neonatal Intensive Care Unit; Receiver Operator Characteristic; Confirmatory Testing; Glucose Measurement;
D O I
10.1186/1471-2431-6-28
中图分类号
学科分类号
摘要
Background: Point of care (POC) glucose meters are routinely used as a screening tool for hypoglycemia in a neonatal setting. Glucose meters however, lack the same accuracy as laboratory instruments for glucose measurement. In this study we investigated potential reasons for this inaccuracy and established a cut off value for confirmatory testing. Methods: In this prospective study, all patients in the neonatal intensive care unit who had a plasma glucose test ordered were eligible to participate. Demographic information, sample collection information (nine variables) and a recent hematocrit value were recorded for each sample. Glucose measurements were taken at the bedside on the glucose meter (RN PCx) as well as in the laboratory on both the glucose meter (LAB PCx) and the laboratory analyzer (PG). Data were analyzed by simple and mixed-effects regression analysis and by analysis of a receiver operator characteristics (ROC) curve. Results: There were 475 samples analyzed from 132 patients. RN PCx values were higher than PG values (mean = 4.9%), while LAB PCx results were lower (mean = -5.2%) than PG values. Only 31% of the difference between RN PCx - PG and 46% of the difference for LAB PCx - PG could be accounted for by the variables tested. The largest proportion of variance between PCx and PG measurements was explained by hematocrit (about 30%) with a greater effect seen at glucose concentrations ≤4.0 mmol/L (≤72 mg/dL)(48% and 40% for RN PCx and LAB PCx, respectively). The ROC analysis showed that for detection of all cases of hypoglycemia (PG < 2.6 mmol/L)(PG < 47 mg/dL) the PCx screening cut off value would need to be set at 3.8 mmol/L (68 mg/dL) requiring 20% of all samples to have confirmatory analysis by the laboratory method. Conclusion: The large difference between glucose results obtained by PCx glucose meter compared to the laboratory analyzer can be explained in part by hematocrit and low glucose concentration. These results emphasize that the glucose meter is useful only as a screening device for neonatal hypoglycemia and that a screening cut off value must be established. © 2006 Balion et al; licensee BioMed Central Ltd.
引用
收藏
相关论文
共 21 条
[1]  
Deshpande S., Platt M.W., The investigation and management of neonatal hypoglycaemia, Semin Fetal Neonatal Med, 10, pp. 351-361, (2005)
[2]  
Cornblath M., Schwartz R., Aynsley-Green A., Lloyd J.K., Hypoglycemia in infancy: The need for a rational definition. A Ciba Foundation discussion meeting, Pediatrics, 85, pp. 834-837, (1990)
[3]  
Cornblath M., Hawdon J.M., Williams A.F., Aynsley-Green A., Ward-Platt M.P., Schwartz R., Kalhan S.C., Controversies regarding definition of neonatal hypoglycemia: Suggested operational thresholds, Pediatrics, 105, pp. 1141-1145, (2000)
[4]  
Stanley C.A., Baker L., The causes of neonatal hypoglycemia, NEJM, 340, pp. 1200-1201, (1999)
[5]  
Screening guidelines for newborns at risk for low blood glucose, Paediatr Child Health, 9, pp. 723-729, (2004)
[6]  
Self-monitoring of blood glucose consensus statement, Diabetes Care, 19, (1996)
[7]  
Requirements for in vitro blood glucose monitoring systems for self-testing in managing diabetes mellitus, (2003)
[8]  
Kost G.J., Vu H.T., Lee J.H., Bourgeois P., Kiechle F.L., Martin C., Miller S.S., Okorodudu A.O., Podczasy J.J., Webster R., Witlow K.J., Multicentre study of oxygen-insensitive handheld glucose point-of-care testing in critical care/hospital/ambulatory patients in the United States and Canada, Crit Care Med, 26, pp. 581-590, (1998)
[9]  
Ho H.T., Yeung W.K.Y., Young B.W.Y., Evaluation of "point of care" devices in the measurement of low blood glucose in neonatal practice, Arch Dis Child Fetal Neonatal Ed, 89, (2003)
[10]  
St-Louis P., Ethier J., An evaluation of three glucose meters and their performance in relation to criteria of acceptability for neonatal specimens, Clin Chim Acta, 322, pp. 130-148, (2002)